Your browser doesn't support javascript.
loading
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer.
Trüb, Marta; Uhlenbrock, Franziska; Claus, Christina; Herzig, Petra; Thelen, Martin; Karanikas, Vaios; Bacac, Marina; Amann, Maria; Albrecht, Rosemarie; Ferrara-Koller, Claudia; Thommen, Daniela; Rothschield, Sacha; Savic Prince, Spasenija; Mertz, Kirsten D; Cathomas, Gieri; Rosenberg, Robert; Heinzelmann-Schwarz, Viola; Wiese, Mark; Lardinois, Didier; Umana, Pablo; Klein, Christian; Laubli, Heinz; Kashyap, Abhishek S; Zippelius, Alfred.
Afiliación
  • Trüb M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Uhlenbrock F; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Claus C; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Herzig P; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Thelen M; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Karanikas V; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Bacac M; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Amann M; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Albrecht R; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Ferrara-Koller C; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Thommen D; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Rothschield S; Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Savic Prince S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Mertz KD; Institute of Pathology, Cantonal Hospital Basel-Landschaft, Liestal, Switzerland.
  • Cathomas G; Institute of Pathology, Cantonal Hospital Basel-Landschaft, Liestal, Switzerland.
  • Rosenberg R; Department of Surgery, Cantonal Hospital Basel-Landschaft, Liestal, Switzerland.
  • Heinzelmann-Schwarz V; Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland.
  • Wiese M; Division of Thoracic Surgery, University Hospital Basel, Basel, Switzerland.
  • Lardinois D; Division of Thoracic Surgery, University Hospital Basel, Basel, Switzerland.
  • Umana P; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Klein C; Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Laubli H; Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Kashyap AS; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Zippelius A; Medical Oncology, University Hospital Basel, Basel, Switzerland alfred.zippelius@usb.ch.
J Immunother Cancer ; 8(2)2020 07.
Article en En | MEDLINE | ID: mdl-32616554
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Ligando 4-1BB / Fibroblastos / Inmunoterapia / Neoplasias Límite: Aged / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Ligando 4-1BB / Fibroblastos / Inmunoterapia / Neoplasias Límite: Aged / Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Suiza